Procedure: fluoroscopic swallow evaluation (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 6 | パーキンソン病 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03321019 (ClinicalTrials.gov) | December 12, 2017 | 20/10/2017 | Airway Protective Mechanisms in PD (R01) | Mechanisms of Airway Protection Dysfunction in Parkinson's Disease | Parkinson Disease | Drug: Capsaicin;Device: Resistive respiratory loads;Other: Event-related evoked potential using electroencephalography (EEG).;Procedure: Fluoroscopic swallow evaluation | University of Florida | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Recruiting | 45 Years | 85 Years | All | 260 | United States |